AngioDynamics Statistics
Share Statistics
AngioDynamics has 40.63M shares outstanding. The number of shares has increased by 1.95% in one year.
| Shares Outstanding | 40.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.89% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 38.70M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.00M, so 2.46% of the outstanding shares have been sold short.
| Short Interest | 1.00M |
| Short % of Shares Out | 2.46% |
| Short % of Float | 2.59% |
| Short Ratio (days to cover) | 1.8 |
Valuation Ratios
The PE ratio is -1.38 and the forward PE ratio is -29.75.
| PE Ratio | -1.38 |
| Forward PE | -29.75 |
| PS Ratio | 0.83 |
| Forward PS | 1.2 |
| PB Ratio | 1.23 |
| P/FCF Ratio | -7.47 |
| PEG Ratio | n/a |
Enterprise Valuation
AngioDynamics Inc. has an Enterprise Value (EV) of 378.68M.
| EV / Earnings | -2.05 |
| EV / Sales | 1.25 |
| EV / EBITDA | -26.5 |
| EV / EBIT | -1.97 |
| EV / FCF | -11.16 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.
| Current Ratio | 2.12 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.9% and return on capital (ROIC) is -87.53%.
| Return on Equity (ROE) | -0.9% |
| Return on Assets (ROA) | -0.58% |
| Return on Capital (ROIC) | -87.53% |
| Revenue Per Employee | 406.30K |
| Profits Per Employee | -246.46K |
| Employee Count | 748 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 2.46 |
Taxes
| Income Tax | -7.29M |
| Effective Tax Rate | 0.04 |
Stock Price Statistics
The stock price has increased by 45.3% in the last 52 weeks. The beta is 0.67, so AngioDynamics 's price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | 45.3% |
| 50-Day Moving Average | 7.74 |
| 200-Day Moving Average | 6.91 |
| Relative Strength Index (RSI) | 65.07 |
| Average Volume (20 Days) | 540.15K |
Income Statement
In the last 12 months, AngioDynamics had revenue of 303.91M and earned -184.35M in profits. Earnings per share was -4.59.
| Revenue | 303.91M |
| Gross Profit | 154.70M |
| Operating Income | -192.44M |
| Net Income | -184.35M |
| EBITDA | -14.29M |
| EBIT | -192.44M |
| Earnings Per Share (EPS) | -4.59 |
Balance Sheet
The company has 76.06M in cash and 5.91M in debt, giving a net cash position of 70.14M.
| Cash & Cash Equivalents | 76.06M |
| Total Debt | 5.91M |
| Net Cash | 70.14M |
| Retained Earnings | -395.20M |
| Total Assets | 293.63M |
| Working Capital | 95.89M |
Cash Flow
In the last 12 months, operating cash flow was -28.16M and capital expenditures -5.77M, giving a free cash flow of -33.93M.
| Operating Cash Flow | -28.16M |
| Capital Expenditures | -5.77M |
| Free Cash Flow | -33.93M |
| FCF Per Share | -0.84 |
Margins
Gross margin is 5.09K%, with operating and profit margins of -6.33K% and -6.07K%.
| Gross Margin | 5.09K% |
| Operating Margin | -6.33K% |
| Pretax Margin | -6.31K% |
| Profit Margin | -6.07K% |
| EBITDA Margin | -4.7% |
| EBIT Margin | -63.32% |
| FCF Margin | -11.16% |
Dividends & Yields
ANGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -49.51% |
| FCF Yield | -9.01% |
Analyst Forecast
The average price target for ANGO is $12, which is 29.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 29.4% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 3 |